MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Food as medicine: diet trial aims to stop cancer before it starts
Prevention Recruiting nowThis study is testing whether changing what people eat can help prevent two early blood cell conditions (MGUS and SMM) from turning into cancer. Researchers will compare a plant-based diet, omega-3 and curcumin supplements, or a placebo in 150 participants over 12 weeks. They're …
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Mar 23, 2026 15:16 UTC
-
Tracking the path to myeloma: can we predict cancer before it strikes?
Knowledge-focused Recruiting nowThis study aims to understand why some people with early, symptom-free blood cell conditions (MGUS or smoldering myeloma) develop full multiple myeloma while others don't. Researchers will follow 200 patients for 3 years, collecting blood samples and tracking their health to iden…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Massive ohio study tracks 5,000 blood cancer patients to find better treatments
Knowledge-focused Recruiting nowThis study is creating a large registry of patients in Ohio with multiple myeloma and related blood disorders. Researchers will track patients' treatments, health outcomes, and quality of life over time to understand these diseases better. The registry also helps connect patients…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Could your sleep affect your blood cancer risk?
Knowledge-focused Recruiting nowThis study aims to understand if sleep apnea influences the progression of two related blood conditions: MGUS and multiple myeloma. Researchers are enrolling 200 patients who are already scheduled for a standard bone marrow biopsy. They will collect these samples to compare gene …
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Michael Tomasson • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Can two weeks of Plant-Based eating change your gut to fight cancer risk?
Knowledge-focused Recruiting nowThis study aims to understand how short-term dietary changes affect gut bacteria in people with early, pre-cancerous blood conditions (MGUS or SMM). Researchers will remotely enroll 200 participants across the US to follow a plant-based diet or take specific supplements for two w…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
Listening to the silent struggle: study probes hidden worries of patients with early blood disorders
Knowledge-focused Recruiting nowThis study aims to understand the quality of life and anxiety experienced by patients with early-stage blood conditions called MGUS and smoldering myeloma. It involves 400 patients who are already in other related studies at MD Anderson. Participants will fill out questionnaires …
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC